In silico drug sensitivity predicts subgroup-specific therapeutics in medulloblastoma patients is a research paper published in bioRxiv (Cold Spring Harbor Laboratory) (2025). On theSindex it has a DataRank of 0.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: T32 CA009686
National Institutes of Health
Grant: NS118023
NINDS NIH HHS
Grant: R01 NS118023
Fields of Study
Keywords